{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-278582","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2026-06-23T12:45:37+00:00","discovered_at":"2026-06-23T12:50:02.294526+00:00","generated_at":"2026-06-23T12:50:31.732288+00:00","sec_items":["1.01","1.03","2.03","2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Sangamo Therapeutics files for Chapter 11 bankruptcy; enters stalking horse asset sales to Lilly and Astellas","bullets":["Filed voluntary Chapter 11 petition on June 23, 2026; stock suspended from Nasdaq on May 5, 2026, now trades on OTCQB.","Entered stalking horse APA with Lilly for $50M to sell technology platforms including STAC-BBB, zinc finger, Modular Integrase, and prion program.","Entered stalking horse APA with Astellas for $25M upfront plus up to $25M milestones for Fabry disease candidate isaralgagene civaparvovec.","Obtained $30M DIP financing commitment from Northridge ATM, LLC to fund post-petition operations, subject to court approval.","Board approved restructuring eliminating ~51 roles (~40% of workforce); expects $3-4M severance costs; retaining 77 employees."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-278582","json":"https://secwatch.observer/filing/0001193125-26-278582.json","markdown":"https://secwatch.observer/filing/0001193125-26-278582.md","text":"https://secwatch.observer/filing/0001193125-26-278582.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000119312526278582/0001193125-26-278582-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000119312526278582/d161847d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T12:50:31.732288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}